Go back to News
NEWS
GA_P advises Grupo Lamosa on the acquisition of Grupo Baldocer
Gómez-Acebo & Pombo has advised Grupo Lamosa on the acquisition of Grupo Baldocer for €425m (i.e. €354m at closing and a second payment of no less than €71m).
Grupo Lamosa is the world’s second largest ceramics producer, with a presence in 9 countries, focused on the manufacture and marketing of ceramic tiles, adhesives and insulation, with a track record of more than 130 years in the building materials industry.
Last year it manufactured 215.3 million square metres and had a global turnover of €1,700m. The group has a strong position in Latin America, with 19 production plants on the continent, and another in Spain – the Cerámicas Balcaire plant in Call d’Uixó, which is part of Roca Tiles, which the group has also owned since 2021 (an operation in which we also advised Grupo Lamosa).
The GA_P team advising on the process was formed by a team led by Pablo Fernández Cortijo and Constantino Pérez Salgado, partner and of counsel of Corporate and M&A, and Corporate associates Javier Reyna, Carolina Orri and Rodrigo Fernández-Chillón.
Grupo Lamosa is the world’s second largest ceramics producer, with a presence in 9 countries, focused on the manufacture and marketing of ceramic tiles, adhesives and insulation, with a track record of more than 130 years in the building materials industry.
Last year it manufactured 215.3 million square metres and had a global turnover of €1,700m. The group has a strong position in Latin America, with 19 production plants on the continent, and another in Spain – the Cerámicas Balcaire plant in Call d’Uixó, which is part of Roca Tiles, which the group has also owned since 2021 (an operation in which we also advised Grupo Lamosa).
The GA_P team advising on the process was formed by a team led by Pablo Fernández Cortijo and Constantino Pérez Salgado, partner and of counsel of Corporate and M&A, and Corporate associates Javier Reyna, Carolina Orri and Rodrigo Fernández-Chillón.
Lawyer mentioned
Pablo Fernández Cortijo – Partner
Constantino Pérez – Partner
See all lawyers
See less lawyers
Category
Deal
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
¡NEW!
Emails sent by a company to its staff during collective bargaining do not always violate freedom of association
Emails sent by a company to its staff during a negotiation process do not, in and of themselves, constitute anti-union interference or unlawful pressure, provided they fall within the scope of the company’s freedom of expression and the legitimate defence of its business interests.
PUBLICATION
¡NEW!
Public consultation now open on the Royal Decree regulating the requirements for energy sustainability, environmental sustainability, digital resilience and digital sovereignty applicable to data centres
PUBLICATION
31 Jul, 2026
Automotive and Sustainable Mobility No. 31
Summary of legislative and jurisprudential developments relating to the automotive sector.
PUBLICATION
08 Jul, 2026
Are company directors directly liable for torts attributable to the company?
Debt from liability in tort for third-party damage or loss arises directly against the directors, without prejudice to the fact that, pursuant to Article 38 CC, it also arises simultaneously against the company, to which the non-contractual acts or omissions of its directors are also attributed. This is so true that the liable company (in debt, for example, with the tax authorities as the person liable for the surcharge and the tax penalty owed) may bring an action for contribution against its directors after settling the debt.
PUBLICATION
23 Jun, 2026
Pharma & Healthcare No. 49
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
18 Jun, 2026
Royal Decree 415/2026: key aspects of the new health technology assessment system
Royal Decree 415/2026 establishes a unified framework for the assessment of health technologies in Spain, distinguishing between the technical assessment and the administrative decision regarding funding, pricing or inclusion in the service catalogue, and incorporating the requirements of Regulation (EU) 2021/2282. The aspect that raises the most legal questions in this new piece of legislation is the connection between the assessment regulated by the Royal Decree and the procedures for funding, pricing, and inclusion in the service catalogue.
PUBLICATION
15 Jun, 2026
Conclusions on the abuse of temporary public sector employment: finding a balance between domestic laws and EU law
PUBLICATION
09 Jun, 2026
The “serious risk” of financial assistance (Supreme Court (First Chamber) Judgment of 5 May 2026)
This paper critically analyses the Supreme Court ruling of 5May 2026, which applies the prohibition on financial assistance to a case involving the sale of treasury shares with deferred payment to the shareholders of the assisting company.
PUBLICATION
01 Jun, 2026
NGT plant patenting: betwixt and between regulatory continuity and expectations
The evolution of the concept of genetically modified organisms in the European Union in light of new genomic techniques (NGTs) is examined, along with the regulatory response that introduces a distinction between two categories of NGT plants, making the regime more flexible for those that can be considered equivalent to conventional plants. It also highlights that the institutional agreement reflected in the Council’s position represents a significant shift from the case law of the Court of Justice. Regarding patents, it highlights the absence of substantial changes, opting instead for a cautious approach based on transparency, monitoring, and possible future intervention.